Sandra Huicochea Castellanos

Also affiliated with Anna Needs Neuroblastoma Answers, Weill Cornell Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591”.

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

Journal of Clinical Oncology(2023)10.1200/jco.23.00573

N/A

2.6DataRank · unranked

69 citations

Charlene Thomas, Oliver Sartor, Michael Sun, Judith Stangl‐Kremser, Mahelia Bissassar +10 more

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients

Cancers(2020)10.3390/cancers12051138

N/A

0.550DataRank · unranked

38 citations

Christopher C. Riedl, Anita Kumar, Ahmet Doǧan, Peter Gibbs, Michael Weber +4 more

Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer

Lung Cancer(2021)10.1016/j.lungcan.2021.08.020

N/A

0DataRank · unranked

5 citations

Andrew Pagano, Andrew J. Plodkowski, Jeffrey Girshman, Matthew D. Hellmann, Hira Rizvi +6 more

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

Translational Oncology(2022)10.1016/j.tranon.2022.101593

N/A

0DataRank · unranked

6 citations

Kritika Subramanian, Sandra Huicochea Castellanos, Charlene Thomas, Arindam Roy Choudhury, Brett Muench +4 more

Self-reported race and zip code by men with prostate cancer in New York City and association with access to PSMA PET scans.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17007

N/A

0DataRank · unranked

1 citations

Juana Martinez Zuloaga, Kritika Subramanian, Peter Gregos, Mahelia Bissassar, Sharon Singh +13 more

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

Translational Oncology(2021)10.1016/j.tranon.2021.101242

N/A

0DataRank · unranked

18 citations

Kritika Subramanian, Daniel Margolis, Elisabeth O’Dwyer, Joseph R. Osborne, Yuliya Jhanwar +7 more

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men

Scientific Reports(2023)10.1038/s41598-023-35567-w

N/A

0DataRank · unranked

16 citations

J Gil Martínez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson +5 more

Phase I dose-escalation results of prostate-specific membrane antigen-targeted radionuclide therapy (PSMA-TRT) with alpha-radiolabeled antibody 225Ac-J591 and beta-radioligand 177Lu-PSMA I&T.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5018

N/A

0DataRank · unranked

10 citations

Michael Philip Sun, Jones T. Nauseef, Charlene Thomas, Sandra Huicochea Castellanos, Joseph Earl Thomas +12 more

Final results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5074

N/A

0DataRank · unranked

5 citations

Charlene Thomas, Jones T. Nauseef, Oliver Sartor, Michael Philip Sun, Sandra Huicochea Castellanos +14 more

PSMA-targeted actinium-225 therapy in metastatic castration-resistant prostate cancer (mCRPC): Baseline and follow-up PSMA PET parameters associated with outcomes.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5070

N/A

0DataRank · unranked

1 citations

Charlene Thomas, Gabriel Raab, Aaron N. Holmes, Tobechukwu Okobi, Andres Ricaurte‐Fajardo +11 more